Self-assembly of phosphorylated dihydromyricetin as a carrier-free bone targeting nanomedicine with enhanced efficacy for osteoporosis treatment
Osteoporosis (OP) is a common metabolic disease, that mainly affects skeletal system with the features, including reduction bone density, deterioration bone structure, bone pain and increase risk of bone fracture. In this work, a well-known anti-osteoporosis natural compound named as dihydromyriceti...
Saved in:
| Main Authors: | Yanlong Zhong, Shaorong Huang, Peng Luo, Qi Lai, Fengbo Mo, Xinmin Yang, Xiaoyong Zhang, Bin Zhang, Yen Wei, Xiaowei Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Materials & Design |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0264127525005696 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
by: Fei Teng, et al.
Published: (2025-12-01) -
MDA-MB-231 cell apoptosis in vitro induced by dihydromyricetin
by: ZHOU Fang-zhen, et al.
Published: (2012-05-01) -
Does dihydromyricetin protect the kidney following ischemia–reperfusion injury in male rats?
by: Fayez T. Hammad, et al.
Published: (2025-06-01) -
Structural Characterization and Bioactivity Evaluation of Selenium-Modified Dihydromyricetin from Vine Tea
by: Kaixuan Cheng, et al.
Published: (2025-05-01) -
Dihydromyricetin mitigates epilepsy and cognitive impairment via NLRP3 inhibition in rats
by: Qing Li, et al.
Published: (2025-04-01)